BUSINESS Alembic Pharmaceuticals receives USFDA approval for Levothyroxine Sodium Tablets May 22, 2026
Alembic Pharmaceuticals gets USFDA final approval for Amlodipine and Atorvastatin Tablets May 23, 2025
Alembic Pharmaceuticals shares drop 2% as Q4 net profit falls 11.9% YoY to Rs 156.89 crore May 6, 2025
Alembic Pharmaceuticals gets USFDA final approval for Pantoprazole Sodium for Injection, 40 mg/vial Apr 1, 2025
Alembic Pharmaceuticals receives form 483 with one procedural observation after US FDA inspection at Vadodara facility Mar 7, 2025